The PIDS Training Program Committee (TPC) consists of 20 volunteer members whose main goals are to enhance training of Pediatric Infectious Diseases fellows and serve as a resource for fellowship program directors. Our committee achieves these goals in several ways, and we have continued to evolve in order to address trainees’ and Program Directors’ (PDs) needs as they arise.

The Publications Committee is responsible for:

Considering the high rate of unnecessary antibiotic use, several pediatric health organizations have banded together to create new tools for health care providers in order to reduce these prescriptions and fight antibiotic resistance.

A quickly growing measles outbreak that began in southwest Washington, near Portland, Oregon, has caused local officials and the state’s governor to declare a public health emergency. The latest outbreak comes as 2018 saw the second highest number of reported measles cases (349) in the U.S. since 2000, according to a recent update from the Centers for Disease Control and Prevention (CDC). 

The members of the International Affairs Committee (IAC) are delighted to provide an update to the PIDS Membership regarding our activities in 2018. The mission of the IAC is to develop and foster pediatric infectious disease global health activities. PIDS is very fortunate to have numerous domestic and international members and interest and the IAC welcomes the ideas and interest of the PIDS membership. The IAC is also looking forward to welcoming and engaging our new members in activities. is the official site of the IDWeek conference. For your own protection, please use this official site for information, registration, and hotels.


The PIDS IDWeek Program Chairs are pleased  to announce exciting  PIDS-sponsored programming at 2019 IDWeek in Washington DC:


Special Opening Day Session

  • Measles Outbreak – Updates from the US and International Outbreaks and Practical Hospital Management Issues  (Wednesday, October 2 from 1:30PM to 3:15PM)

Interactive Symposia:

  • Challenging Cases in Pediatric Infectious Diseases (Wednesday, October 2 from 1:30PM to 3:15PM)
  • Mano-a Mano:  Impact of Pre-Transplant Respiratory Viral Infection on Post-Transplant Outcomes,   Reverse Syphilis Screening Algorithms,  Kawasaki Treatment Controversies (Friday, October 4 from 10:30AM to 11:45AM)
  • The Year’s Innovations in Pediatric Infectious Diseases (Saturday, October 5 from 3:15PM to 4:30PM)


  • Diagnosis and Management of Congenital CMV  on Both Sides of the Pond (Joint PIDS/ESPID) (Saturday, October 5 from 1:30PM to 3:15PM)
  • Hot Topics in Pediatric Infectious Diseases  (Top Publications of the Year) (Friday, October 4 from 1:45-3:00)
  • Acute Flaccid Myelitis:  State of the Art Clinical and Research
  • A Precision Approach to the Management of Early Onset Neonatal Sepsis (Sunday, October 6 from 8:00AM to 9:00AM)
  • Impact of Early Life Microbiome Disruptions in the Child  (Saturday, October 5 from 1:45PM to 3:00PM)
  • Help or Hype:  Update on Biomarkers in the Management of Infectious Diseases (Thursday, October 3 from 10:30AM to 11:45AM)
  • The Cutting Edge in Pediatric Osteomyelitis  (Friday, October 4 from 3:15PM to 4:30PM)

Named Lectureships/Awards

  • Caroline B. Hall Lectureship (Thursday, October 3 from 3:15PM to 4:30PM)
  • Stanley Plotkin Lectureship in Vaccinology (Friday, October 4 from 4:45PM to 6:00PM)

Meet the Professor

  • Fighting the TB Epidemic in Children and Adolescents – Game Changing Advances in Pediatric TB (Saturday, October 5 from 8:00AM to 9:00AM)
  • Critical and flexible partnerships between the Clinical Microbiology Laboratory and Infection Prevention and Control: Real-time, Sequence-based Investigation of Hospital Outbreaks (Thursday, October 3 from 8:00AM to 9:00AM)

Original Research

  • 3 Oral Abstract Sessions:  Emerging Viral Infections, Viral Infections, Bacterial Infections (Thrusday - Saturday, October 3-5 from 1:45PM to 3:00PM)
  • Poster Sessions (Thrusday - Saturday, October 3-5 from 12:15PM to 12:45PM)


To register for IDWeek or to view the Interactive Program, visit the official website at



The use of antibiotics drives the development of antibiotic resistance, a major threat to public health worldwide. But these drugs also carry the risk of harm to individual patients, including children. According to a new analysis published in the Journal of the Pediatric Infectious Diseases Society, antibiotics led to nearly 70,000 estimated emergency room visits in the U.S. each year from 2011-2015 for allergic reactions and other side effects in children. The study helps quantify the risk posed by specific antibiotics in children across different age ranges.

“For parents and other caregivers of children, these findings are a reminder that while antibiotics save lives when used appropriately, antibiotics also can harm children and should only be used when needed,” said lead author Maribeth C. Lovegrove, MPH, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention. “For health care providers, these findings are a reminder that adverse effects from antibiotics are common and can be clinically significant and consequential for pediatric patients.”

Discussions regarding “cost” and “value” seem to dominate every conversation about healthcare these days. In a recent editorial in the Journal of the Pediatric Infectious Diseases Society, PIDS immediate past-president Dr. Gilsdorf and colleagues commented that pediatric infectious disease physicians’ “compensation, which is determined by leaders of pediatric departments and hospitals, does not take into account our overall value to the hospital in clinical and nonclinical work as well as in potential cost-saving activities.” This is an appropriate lead-in to an article published in the June 2018 issue of JPIDS by researchers from Doernbecher Children’s Hospital in Portland, Oregon entitled “Utilizing a Modified Care Coordination Measurement Tool to Capture Value for a Pediatric Outpatient Parenteral and Prolonged Oral Antibiotic Therapy Program.” This article sought to determine the amount of time spent by pediatric infectious disease providers on non-reimbursable care coordination activities in the context of a pediatric outpatient antimicrobial therapy program (OPAT).

As we begin the 2019 program planning process, the PIDS Program and Meetings Committee (PMC) would like to encourage all members to consider submitting Invited Science session proposals for the Pediatric Academic Societies (PAS) and IDWeek Meetings. If you can recall, the society’s strategy for our major meetings changed to align with our priorities. For the PAS Meeting, we are encouraging programming that focuses primarily on sessions serving the clinical and educational needs of a broader audience, especially ID topics that will be useful to both ID and other specialties represented at this meeting. For the IDWeek Meeting, session proposals should focus on cutting-edge science and emerging infections. Example topic areas for both meetings are listed below.

For several years the AAP Section on Infectious Diseases has been working with the AAP Committee on Coding and Nomenclature to promote the publishing of values for the Interprofessional Telephone/Internet Consultation CPT codes (99446-99449) for specialties that frequently provide telephone advice without formal consultation from other physicians. Infectious Diseases is among the specialties most frequently providing such advice.  We are happy to announce to the PIDS membership that CPT codes for this activity approved in 2014 now have wRVUs assigned for the four codes below which vary only in the amount of time spent in consultation.

“The Challenges of Viral Respiratory Healthcare-Associated Infections in Pediatrics”
Quach C, Shah R, Rubin LG. Burden of healthcare-associated viral respiratory infections in children’s hospitals. JPIDS. 2018; 7(1): 18-24.

Many parents have questions about their children’s vaccines. Although you may not provide routine immunizations as an infectious disease specialist, you can still serve as a trusted information resource for parents. CDC’s National Center for Immunization and Respiratory Diseases (NCIRD) has a number of resources available to help you talk with parents about vaccines:

Pediatric ID specialists are viewed by administrators and other physicians as valuable contributors to the delivery of high quality medical care, according to a new study published in Hospital Pediatrics. Their contributions in many areas, however, can be difficult to measure, which may lead administrators to overlook their value and under-allocate resources, the findings suggest.

The latest Journal Citation Reports® have recently been released, and we are excited to announce that Journal of the Pediatric Infectious Diseases Society (JPIDS) has received its first Impact Factor.  The journal's Impact Factor is 2.456.


Paul Auwaerter, MD, MBA, President IDSA
Melanie Thompson, MD, Chair HIVMA
Paul Spearman, MD, FPIDS, President PIDS
Keith Kaye, MD, MPH, FSHEA


IDSA: Jennifer Morales This email address is being protected from spambots. You need JavaScript enabled to view it.

PCI Public Relations (312) 558-1770 This email address is being protected from spambots. You need JavaScript enabled to view it.

House Passes Bills that Address Infections Related to the Opioid Epidemic


Statement of the Infectious Diseases Society of America, the HIV Medicine Association and the Pediatric Infectious Diseases Society 

Contact: IDSA: Jennifer Morales This email address is being protected from spambots. You need JavaScript enabled to view it.

PCI Public Relations (312) 558-1770 This email address is being protected from spambots. You need JavaScript enabled to view it.